Company Filing History:
Years Active: 2023
Title: Björn Andersson: Innovator in Radiation Therapy Optimization
Introduction
Björn Andersson is a notable inventor based in Uppsala, Sweden. He has made significant contributions to the field of radiation therapy through his innovative patent. His work focuses on optimizing treatment plans, which is crucial for improving patient outcomes in cancer treatment.
Latest Patents
Björn holds a patent titled "Optimizing a treatment plan based on a score function depending on a quality function." This patent describes a method for optimizing a treatment plan for use in radiation therapy. The method involves several steps, including obtaining a first quality function of the treatment plan, which yields an output value based on an input treatment plan. It also includes obtaining a first pair of input values and a slope indicator, which associates a value of the first quality function to a value of a score. The process constructs a score function that maps values of the first quality function to values of the score by fitting a curve to the first pair of input values and the slope indicator. Finally, the treatment plan is optimized with respect to the score function by varying the treatment plan to improve or constrain the value of the score function within a feasible range of score values. Björn has 1 patent to his name.
Career Highlights
Björn Andersson is currently employed at Raysearch Laboratories AB, a company known for its advancements in radiation therapy technology. His role at the company allows him to apply his innovative ideas in a practical setting, contributing to the development of cutting-edge treatment planning systems.
Collaborations
Björn collaborates with talented individuals such as Björn Hårdemark and Rasmus Bokrantz. These collaborations enhance the innovative environment at Raysearch Laboratories AB and contribute to the advancement of radiation therapy solutions.
Conclusion
Björn Andersson is a key figure in the field of radiation therapy optimization. His innovative patent and work at Raysearch Laboratories AB demonstrate his commitment to improving treatment plans for better patient outcomes. His contributions are vital in the ongoing evolution of cancer treatment technologies.